Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization.

BACKGROUND Cigarette smoking is known to be deleterious to patients with coronary artery disease, but the effect of smoking on the clinical outcome of percutaneous coronary revascularization is unknown. METHODS Patients who had undergone successful percutaneous coronary revascularization at the Mayo Clinic between 1979 and 1995 were divided into nonsmokers (n=2009), former smokers (those who had stopped smoking before the procedure, n=2259), quitters (those who stopped smoking after the procedure, n=435), and persistent smokers (those who smoked before and after the procedure, n=734). RESULTS The maximal follow-up was 16 years (mean [+/-SD], 4.5+/-3.4). The nonsmokers and former smokers had similar base-line characteristics and outcomes. The quitters and persistent smokers were younger than the nonsmokers and former smokers and had more favorable clinical and angiographic characteristics. In analyses adjusted for confounding base-line characteristics, the persistent smokers had a greater relative risk of death (1.76 [95 percent confidence interval, 1.37 to 2.26]) and of Q-wave infarction (2.08 [95 percent confidence interval, 1.16 to 3.72]) than the nonsmokers. The quitters and persistent smokers were less likely than the nonsmokers to undergo additional percutaneous coronary procedures (relative risk, 0.80 [95 percent confidence interval, 0.64 to 0.98] and 0.67 [95 percent confidence interval, 0.56 to 0.81], respectively) or coronary bypass surgery (relative risk, 0.72 [95 percent confidence interval, 0.54 to 0.95] and 0.68 [95 percent confidence interval, 0.54 to 0.86], respectively). The persistent smokers were also at greater risk for death than the quitters (relative risk, 1.44 [95 percent confidence interval, 1.02 to 2.11]). CONCLUSIONS Patients who continued to smoke after successful percutaneous coronary revascularization were at greater risk for Q-wave infarction and death than nonsmokers. The cessation of smoking either before or after percutaneous revascularization was beneficial. Patients undergoing percutaneous revascularization should be encouraged to stop smoking.

[1]  J. Powell,et al.  Arterial bypass surgery and smokers , 1994, BMJ.

[2]  K. Bailey,et al.  Percutaneous transluminal angioplasty in patients with multivessel coronary disease: how important is complete revascularization for cardiac event-free survival? , 1990, Journal of the American College of Cardiology.

[3]  M. Emond,et al.  Long‐term Survival of Medically Treated Patients in the Coronary Artery Surgery Study (CASS) Registry , 1994, Circulation.

[4]  R. Califf,et al.  Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded , 1995, Journal of the American College of Cardiology.

[5]  A. Penn,et al.  Dose-dependent size increases of aortic lesions following chronic exposure to 7,12-dimethylbenz(a)anthracene. , 1981, Cancer research.

[6]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[7]  R. Diaz,et al.  Significance of Smoking in Patients Receiving Thrombolytic Therapy for Acute Myocardial Infarction Experience Gleaned From the International Tissue Plasminogen Activator/Streptokinase Mortality Trial , 1993, Circulation.

[8]  W. Kannel,et al.  Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. , 1974, Lancet.

[9]  R. Califf,et al.  Effect of Cigarette Smoking on Outcome After Thrombolytic Therapy for Myocardial Infarction , 1991 .

[10]  E. Simonson,et al.  The Electrocardiogram in Population Studies: A Classification System , 1960, Circulation.

[11]  D. Waters,et al.  Effects of Cigarette Smoking on the Angiographic Evolution of Coronary Atherosclerosis: A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy , 1996 .

[12]  S Campbell,et al.  Effect of smoking on the activity of ischemic heart disease. , 1989, JAMA.

[13]  L. Campeau.  Letter: Grading of angina pectoris. , 1976, Circulation.

[14]  W. Laskey,et al.  Acute coronary vasoconstrictive effects of cigarette smoking in coronary heart disease. , 1984, The American journal of cardiology.

[15]  R. Diaz,et al.  Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. , 1995, European heart journal.

[16]  B. Gersh,et al.  Effect of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the coronary artery surgery study (CASS): 10-Year follow-up , 1992 .

[17]  S M Ernst,et al.  Smoking and cardiac events after venous coronary bypass surgery. A 15-year follow-up study. , 1996, Circulation.

[18]  S. Shapiro,et al.  The risk of myocardial infarction after quitting smoking in men under 55 years of age. , 1985, The New England journal of medicine.

[19]  L. Klein,et al.  Importance of total life consumption of cigarettes as a risk factor for coronary artery disease. , 1985, American Journal of Cardiology.

[20]  R E Vlietstra,et al.  Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. , 1984, The American journal of cardiology.

[21]  D. Faxon,et al.  Has improvement in PTCA intervention affected long-term prognosis? The NHLBI PTCA Registry experience. , 1995, Circulation.

[22]  L. Dales,et al.  Mortality in middle-aged smokers and nonsmokers. , 1979, The New England journal of medicine.

[23]  B. Chaitman,et al.  Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty. , 1988, The American journal of cardiology.

[24]  E. Topol,et al.  Multiple vessel coronary angioplasty: classification, results, and patterns of restenosis in 494 consecutive patients. , 1987, Catheterization and cardiovascular diagnosis.

[25]  J. Folts,et al.  The Effects of Cigarette Smoke and Nicotine on Platelet Thrombus Formation in Stenosed Dog Coronary Arteries: Inhibition with Phentolamine , 1982, Circulation.

[26]  R. Arora,et al.  Restenosis after transluminal coronary angioplasty: a risk factor analysis. , 1990, Catheterization and cardiovascular diagnosis.

[27]  M. J. Underwood,et al.  Coronary bypass surgery should not be offered to smokers. , 1993, BMJ.

[28]  Thomas J. Ryan,et al.  Guidelines for Percutaneous Transluminal Coronary Angioplasty A Report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty) , 1993, Circulation.